Related Experiment Video
Updated: Jul 10, 2025

05:28
Demonstration of Heterologous Complexes formed by Golgi-Resident Type III Membrane Proteins using Split Luciferase Complementation Assay
Published on: September 10, 2020
2.4K
Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in Pseudomonas aeruginosa Using Split
Hanling Guo1, Emily J Geddes2, Timothy J Opperman2
1Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, Massachusetts 01003, United States.
ACS Infectious Diseases
|November 18, 2023
Summary
A new assay detects the assembly of the Type 3 secretion system (T3SS) translocon in Pseudomonas aeruginosa. This tool aids in developing new drugs to combat dangerous, drug-resistant bacterial infections.
Area of Science:
- Microbiology and Infectious Diseases
- Molecular Biology
- Drug Discovery
Background:
- Multi-drug-resistant *Pseudomonas aeruginosa* is a significant threat in healthcare settings.
- The Type 3 secretion system (T3SS) is a key virulence factor in *P. aeruginosa* pathogenesis.
- T3SS translocon assembly is essential for virulence and a potential therapeutic target.
Purpose of the Study:
- To develop a novel whole-cell-based assay for detecting T3SS translocon assembly.
- To establish a high-throughput screening method for identifying inhibitors of T3SS assembly.
Main Methods:
- Utilized a split NanoLuc luciferase reporter system for translocon assembly readout.
- Developed a whole-cell assay to monitor the protrusion of PopD N-terminus into host cells.
- Assessed assay performance using signal/noise ratio and Z'-factor for robustness.
Main Results:
- The novel assay successfully detected functional T3SS translocon assembly.
- Achieved a favorable signal/noise ratio of 13.6.
- Demonstrated assay robustness with a Z'-factor of 0.67, suitable for high-throughput screening.
Conclusions:
- A novel, robust whole-cell assay for T3SS translocon assembly has been developed.
- This assay is suitable for high-throughput screening of small-molecule inhibitors.
- The findings facilitate the development of new therapeutic strategies against *P. aeruginosa* infections.

